- Home
- IONS vs ETSY Comparison
IONS vs ETSY Comparison
Compare IONS & ETSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IONS
- ETSY
- Stock Information
- Founded
- IONS 1989
- ETSY 2005
- Country
- IONS United States
- ETSY United States
- Employees
- IONS N/A
- ETSY N/A
- Industry
- IONS Biotechnology: Pharmaceutical Preparations
- ETSY Business Services
- Sector
- IONS Health Care
- ETSY Consumer Discretionary
- Exchange
- IONS Nasdaq
- ETSY Nasdaq
- Market Cap
- IONS 6.8B
- ETSY 6.4B
- IPO Year
- IONS 1991
- ETSY 2015
- Fundamental
- Price
- IONS $69.15
- ETSY $71.66
- Analyst Decision
- IONS Strong Buy
- ETSY Hold
- Analyst Count
- IONS 18
- ETSY 28
- Target Price
- IONS $72.83
- ETSY $58.63
- AVG Volume (30 Days)
- IONS 2.2M
- ETSY 7.5M
- Earning Date
- IONS 11-05-2025
- ETSY 10-29-2025
- Dividend Yield
- IONS N/A
- ETSY N/A
- EPS Growth
- IONS N/A
- ETSY N/A
- EPS
- IONS N/A
- ETSY 1.43
- Revenue
- IONS $944,050,000.00
- ETSY $2,838,411,000.00
- Revenue This Year
- IONS $24.01
- ETSY $3.16
- Revenue Next Year
- IONS $4.06
- ETSY $2.14
- P/E Ratio
- IONS N/A
- ETSY $50.72
- Revenue Growth
- IONS 16.05
- ETSY 2.38
- 52 Week Low
- IONS $23.95
- ETSY $40.05
- 52 Week High
- IONS $69.25
- ETSY $76.52
- Technical
- Relative Strength Index (RSI)
- IONS 80.12
- ETSY 62.79
- Support Level
- IONS $61.03
- ETSY $61.71
- Resistance Level
- IONS $63.18
- ETSY $76.52
- Average True Range (ATR)
- IONS 1.63
- ETSY 3.83
- MACD
- IONS 0.02
- ETSY 1.03
- Stochastic Oscillator
- IONS 89.41
- ETSY 74.17
About IONS Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis received FDA approval in 2024 for Tryngolza for a rare high-triglyceride syndrome, marking its first independent launch.
About ETSY Etsy Inc.
Etsy operates a top-10 e-commerce marketplace in the US and the UK, with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $12.5 billion in 2024 consolidated gross merchandise volume, Etsy has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. The firm connects about 95 million buyers and 8 million sellers on its marketplace properties: Etsy and Depop (clothing resale).